Verrica Pharmaceuticals (VRCA) Other Accumulated Expenses (2017 - 2025)
Verrica Pharmaceuticals (VRCA) posted quarterly Other Accumulated Expenses of $366000.0 for Q2 2025, up 21.59% year-over-year from $301000.0 in Q2 2024, and up 120.48% quarter-over-quarter from $166000.0 in Q1 2025.
Verrica Pharmaceuticals (VRCA) Other Accumulated Expenses (2017 - 2025) Analysis & Trends
Verrica Pharmaceuticals' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $366000.0 for Q2 2025.
- In Q2 2025, Other Accumulated Expenses rose 21.59% year-over-year to $366000.0; the TTM figure through Jun 2025 stood at $366000.0 (up 21.59% YoY), while the FY2024 annual figure was $105000.0, down 56.97% from the prior year.
- Other Accumulated Expenses for Q2 2025 stood at $366000.0, up from $166000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $428000.0 in Q3 2024, with the low at $105000.0 in Q4 2024.
- The 3-year median for Other Accumulated Expenses is $291500.0 (2023), against an average of $276625.0.
- Peak annual rise in Other Accumulated Expenses reached 51.77% in 2024, while the deepest fall reached 56.97% in 2024.
- Verrica Pharmaceuticals' Other Accumulated Expenses stood at $244000.0 in 2023, then plunged by 56.97% to $105000.0 in 2024, then jumped by 248.57% to $366000.0 in 2025.
- Business Quant data shows VRCA's Other Accumulated Expenses at $366000.0 in Q2 2025, $166000.0 in Q1 2025, and $105000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 366,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 244,000.00 |
| Sep 30, 2023 | 282,000.00 |
| Dec 31, 2019 | 19,000.00 |
| Sep 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 57,000.00 |
| Mar 31, 2019 | 66,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Jun 30, 2018 | 184,000.00 |
| Dec 31, 2017 | 38,000.00 |